|Quantity Discounts||1 - 9999|
|1 - 9999|
|1 - 9999|
Savvy drugmakers are using sophisticated computer modeling and forecasting to home in on appropriate dosages. They’re boosting Phase III trial
success and cutting trial costs with advanced computer modeling and forecasting techniques that cut dosage guesswork.
FDAnews has enlisted a top expert on adaptive clinical trials, Olga Marchenko, to walk you through three adaptive-design methods for dose ranging studies. You’ll discover:
Get set for 90 minutes of nonstop learning. And don’t forget your questions! Because this session is web-based and totally interactive, you can email questions and get answers by the time you and your staff log off.That’s right: As many staffers may participate from one location as you like. Since there’s no extra charge ― even if hundreds participate ― it makes sense to invite every executive and staffer with clinical trial responsibilities.
FDAnews has hosted this webinar in the past to strong industry interest. If you missed it the first time around, here’s a second chance. Discover the 10 reasons to use adaptive designs in dose ranging studies.
Olga Marchenko is Director of Biostatistics at i3 Statprobe Inc. and head of the Adaptive Design Consulting Group. A leading expert working with clients and statisticians on adaptive design methodology, she provides strategic leadership for design and analysis of clinical trials and is the senior statistical oversight person on client projects and statistical consulting services. She is a former Pfizer executive with more than 100 clinical trials under her belt.
|Date:||Nov. 9–27, 2009|
|Location:||Your office or conference room (no need to travel!)|
Gather your team for maximum benefit! Your investment is for one dial-in.
We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.
Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600
Registrations may not be cancelled. Please contact customer service to make any substitutions.
Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing